MALAT1 and type 2 diabetes mellitus: In individuals with T2DM and lower extremity arterial disease (LEAD), lncRNA MALAT1 and NLRP3 expression were significantly elevated compared to controls, with MALAT1 levels showing a positive correlation with NLRP3 [144].